Please ensure Javascript is enabled for purposes of website accessibility
Contact us
Home > Products > Assay Kits > ADA Assay Kits
Options+
Options
Confirm
  • Product types
    0 selected
    Assay Kit (302)
    Antibodies (2)
  • Target
    0 selected
    Atezolizumab (3)
    Lorvotuzumab (1)
    Vunakizumab (1)
    Lacnotuzumab (1)
    Anetumab (1)
    Clazakizumab (1)
    Ivuxolimab (1)
    Romiplostim (1)
    Basiliximab (1)
    Varlilumab (1)
    E8L (4)
    Nesvacumab (1)
    Zalifrelimab (1)
    Edrecolomab (1)
    Avelumab (3)
    Tisotumab (1)
    Tiragolumab (2)
    Sacituzumab (1)
    Ontamalimab (1)
    Olokizumab (1)
    Pogalizumab (1)
    Sotrovimab (1)
    Camidanlumab (1)
    Talacotuzumab (1)
    A35R (4)
    Vanucizumab (1)
    Rolinsatamab (1)
    Durvalumab (3)
    Imalumab (1)
    Enoblituzumab (1)
    Semorinemab (1)
    Glembatumumab (1)
    Sirukumab (1)
    Tavolimab (1)
    Casirivimab (1)
    Daclizumab (1)
    Vibecotamab (1)
    Eculizumab (3)
    Lupartumab (1)
    Denosumab (3)
    Depatuxizumab (1)
    Anifrolumab (1)
    Pacmilimab (1)
    Andecaliximab (1)
    Mirzotamab (1)
    Tilavonemab (1)
    Balstilimab (1)
    Ziltivekimab (1)
    Lirilumab (1)
    Imdevimab (1)
    Ibalizumab (1)
    Bimagrumab (1)
    Cetuximab (3)
    Losatuxizumab (1)
    Icrucumab (1)
    Nirsevimab (1)
    Farletuzumab (1)
    Omburtamab (1)
    Zagotenemab (1)
    Cetrelimab (1)
    Cergutuzumab (1)
    Codrituzumab (1)
    F/Fusion glycoprotein F0 (3)
    Tregalizumab (1)
    Daratumumab (3)
    Ifabotuzumab (1)
    Sarilumab (2)
    Necitumumab (1)
    Ieramilimab (1)
    Palivizumab (3)
    Mirvetuximab (1)
    Frovocimab (1)
    Befovacimab (1)
    Nivolumab (5)
    Labetuzumab (1)
    Astegolimab (1)
    Guselkumab (2)
    Zanolimumab (1)
    Eldelumab (1)
    Letolizumab (1)
    Ustekinumab (3)
    Panitumumab (3)
    Mavezelimab (1)
    Suptavumab (1)
    Bevacizumab (3)
    Lodelcizumab (1)
    Concizumab (1)
    Pembrolizumab (3)
    Cabiralizumab (1)
    Belantamab (1)
    Elotuzumab (1)
    Evolocumab (1)
    Lenzilumab (1)
    Itolizumab (1)
    Omalizumab (2)
    Serclutamab (1)
    Favezelimab (1)
    Suvizumab (1)
    Brolucizumab (1)
    Tezepelumab (1)
    Marstacimab (1)
    Sintilimab (1)
    Emactuzumab (1)
    Teclistamab (1)
    Pasotuxizumab (1)
    Alirocumab (1)
    Namilumab (1)
    Cusatuzumab (1)
    RBD (4)
    Tesidolumab (1)
    Indatuximab (1)
    Foravirumab (1)
    Ranibizumab (3)
    Elezanumab (1)
    Obinutuzumab (2)
    Tislelizumab (1)
    Cixutumumab (1)
    Rosopatamab (2)
    RBD (Omicron/BA.5) (3)
    Otilimab (1)
    Vorsetuzumab (1)
    RBD (Delta) (2)
    Tanezumab (1)
    Lintuzumab (1)
    Rafivirumab (1)
    Varisacumab (1)
    Enfortumab (1)
    Afutuzumab (1)
    Toripalimab (1)
    Dalotuzumab (1)
    Figitumumab (1)
    Tarextumab (1)
    dsDNA (1)
    Milatuzumab (1)
    Meplazumab (1)
    Spike glycoprotein (9)
    Adalimumab (3)
    Oleclumab (1)
    Tosatoxumab (1)
    Benufutamab (1)
    Crizanlizumab (1)
    Ianalumab (1)
    Epcoritamab (1)
    Afasevikumab (1)
    Ganitumab (1)
    Urelumab (1)
    Glycoprotein (4)
    Disitamab (1)
    Alacizumab (1)
    Spike Protein (Trimer) (2)
    Certolizumab (2)
    Zampilimab (1)
    Obiltoxaximab (1)
    Conatumumab (1)
    Inclacumab (1)
    Blosozumab (1)
    Glofitamab (1)
    Bimekizumab (1)
    Ixekizumab (1)
    Teprotumumab (1)
    Utomilumab (1)
    GP/Envelope glycoprotein (3)
    Pertuzumab (3)
    Ramucirumab (1)
    NP/Nucleocapsid (3)
    Golimumab (2)
    Vofatamab (1)
    Gremubamab (1)
    Drozitumab (1)
    Olaratumab (1)
    Romosozumab (1)
    Ibritumomab (1)
    Remtolumab (1)
    Apamistamab (1)
    Magrolimab (1)
    Tirzepatide (1)
    Trastuzumab (2)
    Ascrinvacumab (1)
    Etanercept (1)
    Infliximab (2)
    Oxelumab (1)
    A29L (4)
    Lexatumumab (1)
    Tovetumab (1)
    Mirikizumab (2)
    Mosunetuzumab (1)
    Ocaratuzumab (1)
    Secukinumab (2)
    Emibetuzumab (1)
    Sibrotuzumab (1)
    Zanidatamab (1)
    Cinpanemab (1)
    Rituximab (1)
    Canakinumab (1)
    Dupilumab (3)
    M1R (4)
    Tigatuzumab (1)
    Ipilimumab (2)
    Dilpacimab (1)
    Carlumab (1)
    Tibulizumab (1)
    Tocilizumab (3)
    Amatuximab (1)
    Zenocutuzumab (1)
    CD79B (2)
    Natalizumab (2)
    Gevokizumab (1)
    Iscalimab (1)
    H3L (2)
    Faricimab (1)
    Tremelimumab (1)
    Navicixizumab (1)
  • Applications
    0 selected
    ELISA (304)
  • Reactivity
    0 selected
    Nivolumab (2)
  • Host species
    0 selected
    Rabbit (2)
  • Clonality
    0 selected
    Monoclonal (2)
  • Conjugate
    0 selected
    Unconjugated (2)

Quick access

Contact us

  • +33(0)3 90 20 54 70

  • info@abinscience.com

  • 19 rue de la Haye 67300 Schiltigheim France

Copyright © 2025 abinScience. All Rights Reserved. All Products are for Research Use Only